Rightslink® by Copyright Clearance Center

Real-World Evidence in the United States (US) of the Impact of Bridging Therapy Prior to Axicabtagene Ciloleucel (Axi-Cel) for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL)

Author:

Michael Roderick Cook,Roni Shouval,Miguel-Angel Perales,Evandro Bezerra,Alex Niu,Saurabh Dahiya,Loretta J. Nastoupil,Caron A. Jacobson,L. Elizabeth Budde,Amanda L. Olson,Brent R. Logan,Zhen-Huan Hu,Hai-Lin Wang,Zhong-Cheng Luo,Jenny J. Kim et al.

Publication:

Blood

Publisher:

Elsevier

Date:

2 November 2023

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.